donor was identified in Australia. A decision to transplant was made and arrangements were organized. Based on our previous laboratory experience on the stab-A major limitation of unrelated bone marrow transplantation is the duration of time that is safe between ility of bone marrow, our plan was to transport the heparinized (100 units/ml) marrow at room temperature. The harvest and re-infusion of the marrow. We have been able to demonstrate safe re-infusion of bone marrow unmanipulated bone marrow was infused without incident 35 h after harvest. kept at room temperature during transport, after almost 36 h. In vitro colony-forming assays suggest that
Colony studies were not done. Another study suggested that colony formation and long-term culture initiation was unaffected by storage at 4°C for up to 5 days. 4 Clinical results reported here, demonstrates both stability of colony-forming cells, and more importantly, clear evidence of graft viability and durability with at least 35 h delay between harvest and re-infusion. The data presented here would indicate that elaborate additive regimens, cryopreservation and/or storage on ice/dry ice are not necessary for the safe transfer and successful engraftment of donor bone marrow. This should make the fears that some centers have of moving too far afield to procure bone marrow, less intense and open up additional potential donors for patients in need. Virtually no harvest center is too distant for safe transport of bone marrow at room temperature. Again, there appears to be no difference. We then elected
